↓ Skip to main content

Evaluation of HIV+ patients experience with pharmaceutical care based on AMO-methodology

Overview of attention for article published in Farmacia Hospitalaria, September 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of HIV+ patients experience with pharmaceutical care based on AMO-methodology
Published in
Farmacia Hospitalaria, September 2018
DOI 10.7399/fh.10947
Pubmed ID
Authors

María de Gracia Cantillana-Suárez, Mercedes Manzano-García, María de Las Aguas Robustillo-Cortés, Ramón Morillo-Verdugo

Abstract

To evaluate the experience of HIV+ patients with pharmaceutical care based on the ability-motivation-opportunity methodology. Method: Cross-sectional, unicentric study. The participants included were HIV+  patients attended during November-2016 and to whom the IEXPAC  questionnaire was conducted. This validated questionnaire allows to know the  experience of chronic patients about the health care they receive. 91 patients were included. The overall mean score of the IEXPAC  questionnaire was: 9.7 ± 0,3. The items that obtained higher scores were:  respect lifestyle (9.9 ± 0.5); coordination to offer good care (9.9 ± 0.5); helping  to continue treatment (9.9 ± 0.4); making sure that I take medication  (9.9 ± 0.4); worried about well-being (9.9 ± 0.4). The points with the possibility  of improvements included: worried about me when I get home after  being in hospital (8.7 ± 1.2). The evaluation of the pharmaceutical care process based on the  ability-motivation-opportunity model achieve a high level in each of the  identified points of interaction.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 14%
Student > Bachelor 3 14%
Student > Ph. D. Student 3 14%
Student > Doctoral Student 2 9%
Researcher 1 5%
Other 2 9%
Unknown 8 36%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 18%
Medicine and Dentistry 4 18%
Nursing and Health Professions 3 14%
Biochemistry, Genetics and Molecular Biology 1 5%
Business, Management and Accounting 1 5%
Other 0 0%
Unknown 9 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2019.
All research outputs
#17,292,294
of 25,385,509 outputs
Outputs from Farmacia Hospitalaria
#181
of 368 outputs
Outputs of similar age
#222,996
of 345,739 outputs
Outputs of similar age from Farmacia Hospitalaria
#4
of 5 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 368 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,739 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one.